Categories Reseñas

Explainer: Sharpe Ratio – A key metric for risk-adjusted returns

The Sharpe Ratio, developed by Nobel laureate William F. Sharpe, is a key tool for evaluating mutual fund performance. It measures risk-adjusted returns, helping investors assess if the returns justify the risk taken. A higher Sharpe Ratio indicates better performance, while a lower ratio suggests poor risk-adjusted returns.

Categories Reseñas

Hospital stocks’ growth outlook positive: HSBC

HSBC has given a ‘buy’ rating to Krishna Institute of Medical Sciences and Apollo Hospitals, while assigning a ‘reduce’ rating to Global Health and Narayana Hrudayalaya. The brokerage sees a positive growth outlook for the hospital sector due to rising demand for quality healthcare, with several hospitals planning significant bed Continue Reading

Categories Reseñas

Biocon Biologics is planning to raise $950 million through overseas bonds

Biocon Biologics plans to raise $950 million through overseas bond sales to refinance a significant portion of its $1.2-billion debt from acquiring Viatris Inc.’s biosimilars business. The company has already prepaid $250 million and is exploring ways to reduce finance costs. The bond’s rating will determine its pricing.

Categories Reseñas

ICICI Security shareholder moves NCLAT against order on delisting

A shareholder has approached the NCLAT challenging the NCLT’s approval of ICICI Securities’ delisting application. The appeal cites misapplication of regulations, fraudulent voting, and non-transparency concerns. Quantum Mutual Fund and minority shareholders argue that the share swap negatively impacts them. An investor has also moved the Bombay High Court against Continue Reading